Multiomics – Products

Sapient, has launched the next generation of its multi-omics and real-world data (RWD) human biology database, now branded as the DynamiQ™ Insights Engine.

Evotec and Bristol Myers Squibb's collaboration reaches new milestones, advancing their molecular glue-based pipeline with $75 million in payments.

BioSkryb and Tecan’s new integrated solution streamlines single-cell analysis, improving throughput and reducing reliance on cell sorting techniques like FACS.

PGxAI's Deneb model uses AI and multi-omics data to predict patient drug responses, streamlining drug development and reducing trial failures.

Source BioScience has completed the acquisition of Cambridge Clinical Laboratories (CCL), strengthening its clinical diagnostics portfolio. The acquisition adds expertise in personalized healthcare testing and expands Source’s clinical services.

Signios Bio, formerly the US research division of MedGenome, has rebranded to reflect its bold vision in AI-powered bioinformatics and multiomics. With an integrated suite of technologies spanning genomics, proteomics and spatial biology.

Canopy Multiomic Services delivers advanced tools for spatial biology and single-cell omics, supporting biopharma research, assay development, clinical testing, and quality data—guiding your work from discovery to translation

DNAnexus and Alida Biosciences collaborate to advance RNA epigenomics by hosting AlidaBio's EpiScout™ Analysis Suite on the DNAnexus cloud platform.

Explore how this platform eliminate barriers to spatial biology research, empowering scientists to achieve publication-ready results in record time without compromising on experimental flexibility.

Seer, Inc. (Nasdaq: SEER), announced that the company will showcase new findings at the 21st Annual US Human Proteome Organization (HUPO) Conference in Philadelphia, PA, from February 22-26, 2025.